A carregar...
Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum Antitoxin
BACKGROUND: Botulism is a rare, life-threatening paralytic illness. Equine-derived heptavalent botulinum antitoxin (HBAT), the only currently available treatment for noninfant botulism in the United States, was licensed in 2013. No reports have systematically examined safety and clinical benefit of...
Na minha lista:
| Publicado no: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5866099/ https://ncbi.nlm.nih.gov/pubmed/29293928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix816 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|